Drug
Staccato Alprazolam
Staccato Alprazolam: highest development phase Phase 3, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Staccato alprazolam NCT05077904 | Phase 3 | Stereotypical Prolonged Seizures |
Latest
No recent events.
Follow Staccato Alprazolam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.